ACM

Altium Capital Management Portfolio holdings

AUM $34.4M
This Quarter Return
+12.13%
1 Year Return
-2.5%
3 Year Return
+357.21%
5 Year Return
–
10 Year Return
–
AUM
$360M
AUM Growth
+$360M
Cap. Flow
+$80M
Cap. Flow %
22.21%
Top 10 Hldgs %
19.65%
Holding
155
New
61
Increased
18
Reduced
21
Closed
31

Top Buys

1
BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
$8.32M
2
VRCA icon
Verrica Pharmaceuticals
VRCA
$6.88M
3
ALDX icon
Aldeyra Therapeutics
ALDX
$6.51M
4
CDNA icon
CareDx
CDNA
$5.54M
5
NVRO
NEVRO CORP.
NVRO
$5.29M

Top Sells

1
IRD
Opus Genetics, Inc. Common Stock
IRD
$9.71M
2
GNPX icon
Genprex
GNPX
$5.82M
3
ANAB icon
AnaptysBio
ANAB
$5.62M
4
COGT icon
Cogent Biosciences
COGT
$4.86M
5
CLDX icon
Celldex Therapeutics
CLDX
$4.01M

Sector Composition

1 Healthcare 82.98%
2 Financials 2.24%
3 Consumer Staples 0.95%
4 Industrials 0.89%
5 Technology 0.63%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
XENT
51
DELISTED
Intersect ENT, Inc
XENT
$2.96M 0.82%
141,856
+42,195
+42% +$881K
MORF
52
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$2.95M 0.82%
+46,541
New +$2.95M
EYPT icon
53
EyePoint Pharmaceuticals
EYPT
$824M
$2.94M 0.82%
+289,316
New +$2.94M
NUVA
54
DELISTED
NuVasive, Inc.
NUVA
$2.83M 0.79%
+43,133
New +$2.83M
IRON icon
55
Disc Medicine
IRON
$2.14B
$2.76M 0.77%
+203,995
New +$2.76M
PHAS
56
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$2.68M 0.74%
+775,000
New +$2.68M
DYN icon
57
Dyne Therapeutics
DYN
$1.91B
$2.59M 0.72%
+166,636
New +$2.59M
CFMS
58
DELISTED
Conformis, Inc. Common Stock
CFMS
$2.58M 0.72%
+2,608,875
New +$2.58M
MLTX icon
59
MoonLake Immunotherapeutics
MLTX
$3.74B
$2.55M 0.71%
250,000
– –
PROF
60
Profound Medical
PROF
$131M
$2.55M 0.71%
+126,427
New +$2.55M
TMPMU
61
DELISTED
Turmeric Acquisition Corp. Unit
TMPMU
$2.54M 0.71%
254,000
– –
SNCE
62
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$2.54M 0.7%
250,000
– –
CHFW.U
63
DELISTED
Consonance-HFW Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third
CHFW.U
$2.44M 0.68%
250,000
– –
SRSAU
64
DELISTED
Sarissa Capital Acquisition Corp. Unit
SRSAU
$2.44M 0.68%
225,000
– –
CYTK icon
65
Cytokinetics
CYTK
$5.91B
$2.4M 0.67%
+103,262
New +$2.4M
IRD
66
Opus Genetics, Inc. Common Stock
IRD
$73.7M
$2.31M 0.64%
397,036
-1,671,494
-81% -$9.71M
WVE icon
67
Wave Life Sciences
WVE
$1.24B
$2.24M 0.62%
+398,997
New +$2.24M
MEIP icon
68
MEI Pharma
MEIP
$149M
$2.19M 0.61%
+638,083
New +$2.19M
VREX icon
69
Varex Imaging
VREX
$455M
$2.17M 0.6%
+105,727
New +$2.17M
ADMS
70
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
$2.16M 0.6%
+450,000
New +$2.16M
MCRB icon
71
Seres Therapeutics
MCRB
$162M
$2.15M 0.6%
+104,626
New +$2.15M
SYRE icon
72
Spyre Therapeutics
SYRE
$1.01B
$2.12M 0.59%
267,753
– –
PXS icon
73
Pyxis Tankers
PXS
$30.6M
$2.1M 0.58%
+2,035,793
New +$2.1M
CALA
74
DELISTED
Calithera Biosciences, Inc
CALA
$2.07M 0.57%
+853,902
New +$2.07M
HCAQ
75
DELISTED
HealthCor Catalio Acquisition Corp. Class A Ordinary Shares
HCAQ
$2M 0.56%
+200,000
New +$2M
1 2
3
4 5